Skip to main content

Ethical Implications of Nanomedicine: Implications of Imagining New Futures for Medicine

  • Chapter
  • First Online:
Nanomedicine

Part of the book series: Nanostructure Science and Technology ((NST))

Abstract

This chapter considers ethical and social issues arising from applying advances in nanotechnologies to medicine, and more briefly to enhancing the human body. While these are usually enabling technologies, they already embody values and imply trajectories for future medicine which raise important questions. In enabling a move to pre-symptomatic medicine, nano-diagnostics may revolutionise some treatments, but also pose problems. Do we want advanced warning of an untreatable disease? How early in life should we begin to take preventative medication if the onset of a treatable condition is only a probability? Are we all already ‘ill’? Handling, interpreting and counselling the increased information will be important. Nanoscale remote monitoring devices present many practical advantages to the elderly and chronically sick but at the cost of a degree of intrusion by a third party, and a shift of responsibility to the patient and the carer, which may not always be welcome. Targeted drug delivery offers many improvements but also with uncertainties about nanoparticles, side effects and patient variability. Theranostic devices which combine monitoring and therapeutic action still need human controls. In regenerative medicine, nano-scaffolds could enable tissue repair and simple replacements, but major organ constructs, if ever feasible, would need careful ethical assessment. Should nano-enabled interventions in the body become the norm, or used only for particular conditions? There may also be pressure to use devices for other than medical reasons. Human values are needed to modulate engineering logic. Faced with risk and uncertainties, how do we decide when to proceed with a nanomedical intervention, or to exercise precaution? The use of nanotechnologies to enhance the human body are discussed briefly. Important questions include how far we regard the body as ‘given’ or alterable; can we distinguish between medical interventions and enhancements; risks; worsening the rich-poor divide; whether such functional ‘improvements’ really enhance human life when viewed holistically, or when set against more pressing problems facing societies.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. CLINAM (2014) European foundation for clinical nanomedicine. www.clinam.org. Accessed

  2. Mnyusiwalla A, Daar AS, Singer PA (2003) Mind the gap: science and ethics in nanotechnology, nanotechnology. Nanotechnology 14:R9–R13

    Article  Google Scholar 

  3. Bruce DM (2006a) Ethical and social issues in nanobiotechnologies. EMBO Rep 7:754–758

    Google Scholar 

  4. Bruce DM (2006b) Nano2Life ethics: a scoping paper on ethical and social issues in nanobiotechnologies. In: Ach JS, Siep L (eds) Nano-bio-ethics: ethical dimensions of nanobiotechnology. Lit Verlag, Münster, pp 63–83

    Google Scholar 

  5. Bennett DJ, Schuurbiers D (2005) Nanobiotechnology: responsible action on issues in society and ethics (NANOBIO-RAISE). In: Nanotech 2005: technical proceedings of the 2005 NSTI nanotechnology conference and trade show, vol 2, pp. 765–768. http://www.nsti.org/publications/Nanotech/2005/pdf/402.pdf. Accessed 17 Jan 2013

  6. NanoMed Round Table (2011) NanoMed round table: A report on the nanomedicine environment, http://www.philosophie.tu-darmstadt.de/media/institut_fuer_philosophie/diesunddas/nordmann/nanomed.pdf. Accessed 17 and 18 Jan 2013

  7. ObservatoryNANO (2010) ObservatoryNANO 2nd annual report on ethical and societal aspects of nanotechnology, http://www.observatorynano.eu/project/filesystem/files/NanobioethicsApril2010.pdf. 27 Sept 2014

  8. DEEPEN (2009) Deepening ethical engagement and participation in emerging nanotechnologies. http://www.geography.dur.ac.uk/Projects/Default.aspx?alias=www.geography.dur.ac.uk/projects/deepen. Accessed 29 July 2013

  9. EGE (2007) Ethical aspects of nanomedicine, Opinion 21 of the European group on ethics in science and new technologies to the European Union, 17 Jan 2007. European Commission, Brussels. http://ec.europa.eu/bepa/european-group-ethics/docs/publications/opinion_21_nano_en.pdf. Accessed 18 Jan 2013

  10. ETC Group (2003) The big down: Atomtech – technologies converging at the nano-scale. ETC Group, Winnipeg

    Google Scholar 

  11. The Royal Society, The Royal Academy of Engineering (2004) Nanoscience and nanotechnologies: opportunities and uncertainties. The Royal Society, London

    Google Scholar 

  12. European Commission (2005) Eurobarometer 63: public opinion in the European Union, European Commission, Brussels. http://ec.europa.eu/public_opinion/archives/eb_arch_en.htm. Accessed 29 July 2013

  13. Gavelin K, Wilson R, Doubleday R (2007) Democratic nanotechnologies? The final report of the Nanotechnology Engagement group. Involve, London. http://www.involve.org.uk/neg. Accessed 18 Jan 2013

  14. Grobe A, Rissanen M, Funda P, de Beer J and Jonas U (2012) Nanotechnologies from the consumers’ point of view: what consumers know and what they would like to know. Stiftung Risiko Dialog, St Gallen. http://www.risiko-dialog.ch/images/RD-Media/PDF/Themen/Nanotechnologie/Konsumentenstudie_Nano_2011_final.pdf (in German). English summary, http://www.risiko-dialog.ch/images/RD-Media/PDF/Themen/Nanotechnologie/Consumerstudy_Nano_EN.pdf. Accessed 18 Jan 2013

  15. Rathenau Instituut (2011) Governance of nanotechnology in the Netherlands – Informing and engaging in different social spheres. Rathenau Instituut, Den Haag, The Netherlands. http://www.rathenau.nl/en/publications/publication/governance-of-nanotechnology-in-the-netherlands-informing-and-engaging-in-different-social-spher.html. Accessed 18 Jan 2013

  16. DEFRA (2011) Nanotechnologies stakeholder group, 2005–2010. UK Department for the Environment, Food and Rural affairs, London. http://archive.defra.gov.uk/environment/quality/nanotech/research.htm. Accessed 29 July 2013

  17. Friends of the Earth (2006) Nanomaterials, sunscreens and cosmetics. http://nano.foe.org.au/sites/default/files/FoEA%20nano%20cosmetics%20report%202MB.pdf. Accessed 18 Jan 2013

  18. Friends of the Earth (2011) Nano-silver: policy failure puts public health at risk. http://nano.foe.org.au/sites/default/files/Nano-silver_2011%20Aus%20v2%20web.pdf. Accessed 18 Jan 2013

  19. Phillips L (2012) Nanotechnology: armed resistance. Nature 488:576–579, 30 Aug 2012, http://www.nature.com/news/nanotechnology-armed-resistance-1.11287. Accessed 18 Jan 2013

  20. Bhattachary D, Stockley R, Hunter A (2008) Nanotechnology for healthcare, prepared for the Engineering and Physical Sciences Research Council, July 2008. Engineering and Physical Sciences Research Council, Swindon

    Google Scholar 

  21. Davies S, Macnaghten P, Kearnes M (eds) (2009) Reconfiguring responsibility: lessons for public policy (Part 1 of the report on Deepening debate on nanotechnology). Durham University, Durham

    Google Scholar 

  22. Ferrari A, Nordmann A (eds) (2009) Reconfiguring responsibility: lessons for nanoethics (Part 2 of the report on Deepening debate on nanotechnology). Durham University, Durham

    Google Scholar 

  23. General Medical Council (2008) Consent: patients and doctors making decisions together. UK General Medical Council, Manchester. http://www.gmc-uk.org/static/documents/content/Consent_-_English_0911.pdf. Accessed 18 Jan 2013

  24. Frodshamon G (2012) Insurance will continue to be unaffected by predictive genetic tests, says Government. BioNews 663:2 July 2012. http://www.bionews.org.uk/page_154877.asp. Accessed 18 Jan 2013

  25. DoH (2007) See for example, Genetics and Insurance Committee, Sixth report from January 2007 to December 2007. UK Department of Health, London. http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/@dh/@en/documents/digitalasset/dh_084686.pdf. Accessed 18 Jan 2013

  26. Roco MC, Bainbridge WS (eds) (2002) Converging technologies for improving human performances, US National Science Foundation report. US National Science Foundation, Washington, DC

    Google Scholar 

  27. Nordmann A (ed) (2004) Converging technologies and the natural, social and cultural world, report of a European Commission expert group. European Commission, Brussels

    Google Scholar 

  28. Academy of Medical Sciences (2012) Joint academies project on human enhancement and the future of work. Academy of Medical Sciences, London. http://www.acmedsci.ac.uk/p47prid102.html. Accessed 18 Jan 2013

  29. Rathenau Instituut (2012) Human enhancement. Rathenau Instituut, Den Haag, The Netherlands. http://www.rathenau.nl/en/publications/publication/human-enhancement-1.html. Accessed 18 Jan 2013

  30. Savalescu J, Bostrom N (2009) Human enhancement. OUP, Oxford

    Google Scholar 

  31. ETHENTECH (2012) Ethics of enhancement technologies. EC FP7 ETHENTECH project: Final report to the European Commission, 2012, (in press)

    Google Scholar 

  32. Bruce DM (ed) (2007) Human enhancement: ethical reflections on emerging nanobio-technologies, Report of an expert working group of the EC NanoBio-Raise programme. http://www.edinethics.co.uk/nano/enhancement.html

  33. Ferrari A, Coenen C, Grunwald A (2012) Visions and ethics in current discourse on human enhancement. Nanoethics 6:215–229

    Article  Google Scholar 

  34. Nordmann A (2007) If and then: a critique of speculative nanoethics. NanoEthics 1:31–46

    Article  Google Scholar 

  35. Meulen R, Savulescu J, Kahane G (eds) (2011) Enhancing human capacities, Wiley-Blackwell, Oxford. This collection was derived in part from the EC FP6 Science and society project ENHANCE – Enhancing human capacities: ethics, regulation and European policy. http://www.euprojekt.su.se/index.php/kb_83/io_1278/io.html. Accessed 18 Jan 2013

  36. Conference of European Churches (2009) Human enhancement – A discussion document. Conference of European churches (CEC), Strasbourg. http://csc.ceceurope.org/fileadmin/filer/csc/Ethics_Biotechnology/Human_enhancement_final_March_10.pdf. Accessed 18 Jan 2013

  37. Committee of European Catholic Bishops Conferences (2009) On the prospects for improvement of the human being (human enhancement) 25 May 2009, Committee of European catholic bishops conferences (COMECE). Brussels

    Google Scholar 

  38. Bruce D, Bruce A (eds) (1998) Engineering genesis. Earthscan, London, pp 113–114

    Google Scholar 

  39. Bruce DM, Walker P (2012) Democs games on human enhancement played to end June 2012 within the ETHENTECH Project. Submitted to the European Commission, (in press)

    Google Scholar 

  40. Holm S, McNamee M (2011) Physical enhancement: what baseline, whose judgement? In: Enhancing human capacities. Wiley-Blackwell, Oxford, pp 291–303

    Google Scholar 

  41. Jerome JK (1889) Three men in a boat. Penguin, London, pp 7–10

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Donald Bruce .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer Science+Business Media New York

About this chapter

Cite this chapter

Bruce, D. (2014). Ethical Implications of Nanomedicine: Implications of Imagining New Futures for Medicine. In: Ge, Y., Li, S., Wang, S., Moore, R. (eds) Nanomedicine. Nanostructure Science and Technology. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-2140-5_12

Download citation

Publish with us

Policies and ethics